148 related articles for article (PubMed ID: 25120704)
1. Metformin inhibits the proliferation of A549/CDDP cells by activating p38 mitogen-activated protein kinase.
Wang Y; Lin B; Wu J; Zhang H; Wu B
Oncol Lett; 2014 Sep; 8(3):1269-1274. PubMed ID: 25120704
[TBL] [Abstract][Full Text] [Related]
2. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.
Wang LH; Li Y; Yang SN; Wang FY; Hou Y; Cui W; Chen K; Cao Q; Wang S; Zhang TY; Wang ZZ; Xiao W; Yang JY; Wu CF
Br J Cancer; 2014 Jan; 110(2):341-52. PubMed ID: 24300974
[TBL] [Abstract][Full Text] [Related]
3. Dual polymeric prodrug co-assembled nanoparticles with precise ratiometric co-delivery of cisplatin and metformin for lung cancer chemoimmunotherapy.
Yang T; Yu S; Liu L; Sun Y; Lan Y; Ma X; Zhu R; Li L; Hou Y; Liu Y
Biomater Sci; 2020 Oct; 8(20):5698-5714. PubMed ID: 32930254
[TBL] [Abstract][Full Text] [Related]
4. LIMD1 Increases the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin via the GADD45α/p38 MAPK Signaling Pathway.
Zeng X; Wang H; He D; Jia W; Ma R
Front Oncol; 2020; 10():969. PubMed ID: 32754438
[No Abstract] [Full Text] [Related]
5. Metformin reverses the resistance mechanism of lung adenocarcinoma cells that knocks down the Nrf2 gene.
Zhang J; Jiao K; Liu J; Xia Y
Oncol Lett; 2018 Nov; 16(5):6071-6080. PubMed ID: 30333878
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the met receptor tyrosine kinase signaling enhances the chemosensitivity of glioma cell lines to CDDP through activation of p38 MAPK pathway.
Lou X; Zhou Q; Yin Y; Zhou C; Shen Y
Mol Cancer Ther; 2009 May; 8(5):1126-36. PubMed ID: 19435873
[TBL] [Abstract][Full Text] [Related]
7. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].
Zhang MC; Hu CP; Chen Q
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483
[TBL] [Abstract][Full Text] [Related]
8. Trichostatin A sensitizes cisplatin-resistant A549 cells to apoptosis by up-regulating death-associated protein kinase.
Wu J; Hu CP; Gu QH; Li YP; Song M
Acta Pharmacol Sin; 2010 Jan; 31(1):93-101. PubMed ID: 20048748
[TBL] [Abstract][Full Text] [Related]
9. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance.
Brozovic A; Fritz G; Christmann M; Zisowsky J; Jaehde U; Osmak M; Kaina B
Int J Cancer; 2004 Dec; 112(6):974-85. PubMed ID: 15386344
[TBL] [Abstract][Full Text] [Related]
10. Calotropin from Asclepias curasavica induces cell cycle arrest and apoptosis in cisplatin-resistant lung cancer cells.
Mo EP; Zhang RR; Xu J; Zhang H; Wang XX; Tan QT; Liu FL; Jiang RW; Cai SH
Biochem Biophys Res Commun; 2016 Sep; 478(2):710-5. PubMed ID: 27498029
[TBL] [Abstract][Full Text] [Related]
11. Dehydrobruceine B enhances the cisplatin-induced cytotoxicity through regulation of the mitochondrial apoptotic pathway in lung cancer A549 cells.
Huang Z; Yang G; Shen T; Wang X; Li H; Ren D
Biomed Pharmacother; 2017 May; 89():623-631. PubMed ID: 28262615
[TBL] [Abstract][Full Text] [Related]
12. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX
Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
[TBL] [Abstract][Full Text] [Related]
13. Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153.
Wu N; Gu C; Gu H; Hu H; Han Y; Li Q
Neoplasma; 2011; 58(6):482-90. PubMed ID: 21895401
[TBL] [Abstract][Full Text] [Related]
14. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
[TBL] [Abstract][Full Text] [Related]
15. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
Gao J; Meng Q; Zhao Y; Chen X; Cai L
BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
[TBL] [Abstract][Full Text] [Related]
16. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer cell lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin.
Mabuchi S; Ohmichi M; Kimura A; Ikebuchi Y; Hisamoto K; Arimoto-Ishida E; Nishio Y; Takahashi K; Tasaka K; Murata Y
Endocrinology; 2004 Mar; 145(3):1302-13. PubMed ID: 14645110
[TBL] [Abstract][Full Text] [Related]
18. Synergistic anti-tumor activity and mechanisms of total glycosides from Cimicifuga dahurica in combination with cisplatin.
Zhang LL; Si JY; Zhang LJ; Xiao-Wei H; Lin L; Li RY; Chen D; Cao L
Chin J Integr Med; 2016 Jan; ():. PubMed ID: 26825081
[TBL] [Abstract][Full Text] [Related]
19. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.
Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D
J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998
[TBL] [Abstract][Full Text] [Related]
20. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats.
Luo J; Tsuji T; Yasuda H; Sun Y; Fujigaki Y; Hishida A
Nephrol Dial Transplant; 2008 Jul; 23(7):2198-205. PubMed ID: 18385389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
